Institutional investors purchased a net $5.9 million shares of MEIP during the quarter ended December 2013 and now own 57.75% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PALLADIUM PARTNERS LLC Bought 142.00 shares of MEI Pharma Inc